089980 — Sang-A Frontec Co Balance Sheet
0.000.00%
- KR₩246bn
- KR₩308bn
- KR₩172bn
- 40
- 31
- 29
- 21
Annual balance sheet for Sang-A Frontec Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 62,284 | 48,600 | 43,830 | 51,877 | 51,407 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 64,549 | 66,108 | 52,727 | 45,100 | 32,826 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 159,805 | 163,664 | 159,483 | 158,470 | 154,181 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 113,566 | 145,911 | 161,985 | 178,870 | 200,396 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 283,345 | 319,567 | 335,959 | 348,952 | 362,239 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 94,087 | 95,788 | 134,824 | 92,983 | 154,176 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 133,329 | 137,967 | 150,973 | 155,926 | 161,209 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 150,017 | 181,600 | 184,986 | 193,026 | 201,029 |
Total Liabilities & Shareholders' Equity | 283,345 | 319,567 | 335,959 | 348,952 | 362,239 |
Total Common Shares Outstanding |